Cradel Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 24-10-2024
- Paid Up Capital ₹ 40.00 K
as on 24-10-2024
- Company Age 33 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.07 Cr
as on 24-10-2024
- Satisfied Charges ₹ 32.44 Cr
as on 24-10-2024
- Revenue -19.61%
(FY 2023)
- Profit -3348.95%
(FY 2023)
- Ebitda -176.80%
(FY 2023)
- Net Worth
- Total Assets 8.39%
(FY 2023)
About Cradel Pharmaceuticals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 40.00 K .
The company currently has active open charges totaling ₹9.07 Cr. The company has closed loans amounting to ₹32.44 Cr, as per Ministry of Corporate Affairs (MCA) records.
Manab Bakshi, Neelanjana Bindra, and Roochira Guha serve as directors at the Company.
- CIN/LLPIN
U24233WB1991PTC050938
- Company No.
050938
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Feb 1991
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
24 Parganas, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Cradel Pharmaceuticals Pvt Ltd offer?
Cradel Pharmaceuticals Pvt Ltd offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Paper & Paper Made Products, Paper Rolls, Sexual Wellness Products, Fertility Enhancer, Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Chemical Reagents & Catalysts, Amine Compounds.
Who are the key members and board of directors at Cradel Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Roochira Guha  | Director | 16-Jan-2019 | Current |
| Manab Bakshi | Director | 21-Feb-1991 | Current |
| Neelanjana Bindra | Director | 22-Mar-2013 | Current |
Financial Performance of Cradel Pharmaceuticals.
Cradel Pharmaceuticals Pvt Ltd, for the financial year ended 2023, experienced significant reduction in revenue, with a 19.61% decrease. The company also saw a substantial fall in profitability, with a 3348.95% decrease in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cradel Pharmaceuticals?
In 2023, Cradel Pharmaceuticals had a promoter holding of 70.00% and a public holding of 30.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 29 Aug 2023 | ₹1.70 M | Open |
Hdfc Bank Limited Creation Date: 02 Sep 2022 | ₹8.90 Cr | Open |
Tata Capital Financial Services Limited Creation Date: 28 Jun 2021 | ₹6.50 Cr | Satisfied |
How Many Employees Work at Cradel Pharmaceuticals?
Cradel Pharmaceuticals has a workforce of 110 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cradel Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cradel Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
